Eagle Pharmaceuticals, Inc. (EGRX) Trades at $57.08 After Triangle; Marathon Oil (MRO) Sentiment Is 0.92

Marathon Oil Corporation operates as an energy company. The company has market cap of $12.75 billion. It operates through three divisions: North America E&P, International E&P, and Oil Sands Mining. It currently has negative earnings. The North America E&P segment develops, explores for, produces, and markets crude oil and condensate, natural gas liquids , and natural gas in North America.

Eagle Pharmaceuticals, Inc. (EGRX) formed triangle with $55.37 target or 3.00% below today’s $57.08 share price. Eagle Pharmaceuticals, Inc. (EGRX) has $851.73 million valuation. The stock decreased 6.30% or $3.84 during the last trading session, reaching $57.08. About 952,400 shares traded or 279.83% up from the average. Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) has risen 79.40% since February 28, 2017 and is uptrending. It has outperformed by 62.70% the S&P500.

Among 4 analysts covering Eagle Pharma (NASDAQ:EGRX), 3 have Buy rating, 1 Sell and 0 Hold. Therefore 75% are positive. Eagle Pharma had 21 analyst reports since July 29, 2015 according to SRatingsIntel. As per Friday, September 1, the company rating was maintained by RBC Capital Markets. The rating was maintained by Piper Jaffray with “Buy” on Tuesday, January 30. The firm earned “Buy” rating on Friday, February 26 by Mizuho. Piper Jaffray maintained it with “Buy” rating and $11800 target in Tuesday, July 25 report. The company was maintained on Wednesday, August 9 by Piper Jaffray. The firm has “Underperform” rating given on Monday, January 9 by Mizuho. The firm earned “Outperform” rating on Thursday, November 3 by RBC Capital Markets. RBC Capital Markets maintained it with “Buy” rating and $81.0 target in Sunday, November 5 report. The rating was upgraded by Mizuho to “Buy” on Thursday, November 3. The stock has “Sell” rating by Mizuho on Monday, December 18.

Analysts await Marathon Oil Corporation (NYSE:MRO) to report earnings on May, 3. They expect $0.09 earnings per share, up 228.57% or $0.16 from last year’s $-0.07 per share. MRO’s profit will be $76.48M for 41.67 P/E if the $0.09 EPS becomes a reality. After $0.07 actual earnings per share reported by Marathon Oil Corporation for the previous quarter, Wall Street now forecasts 28.57% EPS growth.